Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

6.940
-0.050-0.72%
Volume:359.50K
Turnover:2.49M
Market Cap:5.66B
PE:-17.69
High:7.030
Open:7.010
Low:6.850
Close:6.990
52wk High:12.230
52wk Low:3.910
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.31
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.392
ROE:-7.76%
ROA:-5.07%
PB:1.36
PE(LYR):-17.69
PS:9.14

Loading ...

Xiangxue Pharmaceutical Claims Now Accepting Registrations, Two Categories of Investors Eligible for Compensation

Deep News
·
Jan 28

Nikkei Index Drops 0.2%, Dragged Down by Auto and Pharma Stocks

Deep News
·
Jan 27

Insilico Medicine (03696) Enters into Over HKD 931 Million Drug R&D Collaboration with Qilu Pharmaceutical to Accelerate Innovative Therapies for Cardiovascular and Metabolic Diseases

Stock News
·
Jan 27

ASCLETIS-B (01672) Announces Completion of First Dosing in 13-Week US Phase II Study of Oral Small-Molecule GLP-1R Agonist ASC30 for Diabetes

Stock News
·
Jan 26

Tiankang Pharmaceutical's IPO: Defying Industry Recovery with Declining Performance, Capacity Data in Dispute, and Fundraising for Expansion Raises Questions

Deep News
·
Jan 23

Exclusive Interview with Vas Narasimhan at Davos: AI's Long-Term Impact on Pharma, China's Biotech Sector Now Highly Mature

Deep News
·
Jan 22

Hangzhou Bangshun Pharmaceutical Co., Ltd.-B Submits Listing Application to HKEX

Deep News
·
Jan 22

CSC: China's Pharmaceutical Industry at the Starting Point of Global Value Reassessment, Bullish on Related Innovative Drugs and Pharmaceutical Companies

Stock News
·
Jan 22

Puli Pharmaceutical and Fan Minhua Penalized, Two Executives Receive Warning Letters; Affected Investors Eligible for Compensation Claims

Deep News
·
Jan 22

China Post Securities: AI Drug Development Shifts from Cost Efficiency to Molecular Innovation, Data Production Builds Long-term Barriers

Stock News
·
Jan 22

Guangdong Baoli Pharmaceutical's 4 Billion-Dose Formulation Project Commences Construction, Boosting Logistics and Supply Chain

Deep News
·
Jan 22

Hong Kong Stock Movement | Morimatsu Intl (02155) Surges Over 6% Again as Pharmaceutical Capacity Expands Globally, Company Reports Rapid New Order Growth

Stock News
·
Jan 21

Tuoxin Pharmaceutical (301089.SZ) Subsidiary Xinxiang Pharmaceutical Receives Drug GMP Compliance Inspection Letters

Stock News
·
Jan 20

ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development

Stock News
·
Jan 20

HK Stock Movement | Ascletis Pharma-B (01672) Surges Over 5% Before Noon, ASC30 Shows Significant Competitive Edge, Institutions Highlight High BD Potential

Stock News
·
Jan 20

Insilico Medicine (03696) Secures Over 500 Million HKD Partnership with Hengtai Biotech, AI Drug Discovery Enters Multi-Party Collaboration and Commercialization Test

Stock News
·
Jan 20

OCUMENSION-B (01477): OT-703 Completes Patient Enrollment for Real-World Study in Boao, Hainan

Stock News
·
Jan 20

Ocumension Therapeutics Completes Patient Enrollment in Real-World Study of OT-703 for Diabetic Macular Edema

Reuters
·
Jan 20

US Pharmaceutical Firms Threaten Supply Halt, Demand Price Hikes in Europe

Deep News
·
Jan 19

Nikkei Index Drops 0.4% as Pharma and Shipping Stocks Weigh

Deep News
·
Jan 16